Yahoo Finance Exploring Three High Growth Tech Stocks In The United States
In the last week, the market has been flat, but it is up 22% over the past year with earnings forecast to grow by 15% annually. In this environment, identifying high growth tech stocks that can capitalize on these favorable conditions is crucial for investors seeking robust returns.
Top 10 High Growth Tech Companies In The United States
Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
TG Therapeutics | 28.62% | 43.05% | ★★★★★★ |
Sarepta Therapeutics | 24.22% | 44.94% | ★★★★★★ |
Ardelyx | 27.44% | 65.50% | ★★★★★★ |
Super Micro Computer | 20.62% | 27.13% | ★★★★★★ |
Iris Energy | 65.01% | 111.98% | ★★★★★★ |
G1 Therapeutics | 27.57% | 57.75% | ★★★★★★ |
Invivyd | 42.85% | 71.50% | ★★★★★★ |
Clene | 73.06% | 62.58% | ★★★★★★ |
Seagen | 22.57% | 71.80% | ★★★★★★ |
ImmunoGen | 26.00% | 45.85% | ★★★★★★ |
Click here to see the full list of 249 stocks from our US High Growth Tech and AI Stocks screener.
We'll examine a selection from our screener results.
BioMarin Pharmaceutical
Simply Wall St Growth Rating: ★★★★☆☆
Overview: BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions, with a market cap of $17.20 billion.
Operations: BioMarin focuses on the development and commercialization of innovative therapies, generating $2.59 billion in revenue. The company operates within the pharmaceutical industry, targeting rare diseases and serious medical conditions.
BioMarin Pharmaceutical's earnings surged by 156.6% last year, surpassing the biotech industry's modest 0.5% growth, with revenues forecasted to rise by 9.7% annually, outpacing the US market's 8.7%. The company's R&D expenditure is significant, reflecting its commitment to innovation; recent executive changes bring experienced leaders from Amgen and Roche to drive further advancements in rare disease treatments. Notably, BioMarin reported a revenue increase to $712 million for Q2 2024 from $595 million a year ago and net income of $107 million compared to $56 million previously.
CyberArk Software
Simply Wall St Growth Rating: ★★★★☆☆
Overview: CyberArk Software Ltd., along with its subsidiaries, develops, markets, and sells software-based identity security solutions and services globally, with a market cap of approximately $12.08 billion.
Operations: CyberArk generates revenue primarily from security software and services, totaling $860.60 million. The company focuses on identity security solutions across various regions, including the United States and internationally.
CyberArk Software's revenue is forecasted to grow by 16.5% annually, outpacing the US market's 8.8% growth rate. The company's R&D expenses reflect a strong commitment to innovation, with $224.71 million in Q2 2024 compared to $175.84 million a year ago, contributing significantly to its future prospects. Notably, CyberArk’s earnings are expected to grow by 42.47% per year as it transitions towards profitability within three years, underscoring its potential in the cybersecurity space. Recent client announcements highlight CyberArk's strategic partnerships with major entities like SAP Enterprise Cloud Services and DPD Czech, enhancing their cybersecurity frameworks through the CyberArk Identity Security Platform. These collaborations not only bolster CyberArk’s market presence but also showcase its capability in securing privileged access for high-profile clients across various industries, further driving revenue growth and solidifying its position as a leader in identity security solutions.
PTC
Simply Wall St Growth Rating: ★★★★★☆
Overview: PTC Inc. operates as a software company in the Americas, Europe, and the Asia Pacific with a market cap of $20.89 billion.
Operations: PTC Inc. generates revenue primarily from its CAD/CAM software segment, which accounts for $2.22 billion in sales. The company operates across multiple regions including the Americas, Europe, and the Asia Pacific.
PTC's earnings are forecast to grow at 23.9% annually, significantly outpacing the US market's 15.2%. Despite a recent dip in quarterly revenue to $518.64 million from $542.34 million, net income rose to $68.98 million from $61.4 million year-over-year, reflecting operational resilience and cost management efficiency. The company's R&D expenditure underscores its commitment to innovation, with significant investments driving future growth prospects in the software sector transitioning towards SaaS models for recurring revenue stability.
Unlock comprehensive insights into our analysis of PTC stock in this health report.
Evaluate PTC's historical performance by accessing our past performance report.
Where To Now?
Get an in-depth perspective on all 249 US High Growth Tech and AI Stocks by using our screener here.
Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.
Curious About Other Options?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGS:BMRN NasdaqGS:CYBR and NasdaqGS:PTC.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
